Contact
    Start Publications pH-Responsive Drug Delivery Nanoplatforms as Smart Carriers of ...
    ←  Publication Finder
    QSense

    pH-Responsive Drug Delivery Nanoplatforms as Smart Carriers of Unsymmetrical Bisacridines for Targeted Cancer Therapy

    Year: 2023

    Authors: Pilch, Joanna; Potęga, Agnieszka; Kowalczyk, Agata; Kasprzak, Artur; Kowalik, Patrycja; Bujak, Piotr; Paluszkiewicz, Ewa; Augustin, Ewa; Nowicka, Anna M.

    Keywords: drug delivery nanosystem; drug release; folic acid; lysosomal content; quantum dots; targeted cancer therapy; unsymmetrical bisacridines

    Selective therapy and controlled drug release at an intracellular level remain key challenges for effective cancer treatment. Here, we employed folic acid (FA) as a self-navigating molecule in nanoconjugates containing quantum dots (QDs) and β-cyclodextrin (β-CD) for the delivery of antitumor unsymmetrical bisacridine compound (C-2028) to lung and prostate cancers as well as normal cells. The bisacridine derivative can form the inclusion complex with β-cyclodextrin molecule, due to the presence of a planar fragment in its structure. The stability of such a complex is pH-dependent. The drug release profile at different pH values and the mechanism of C-2028 release from QDs-β-CD-FA nanoconjugates were investigated. Next, the intracellular fate of compounds and their influence on lysosomal content in the cells were also studied. Confocal Laser Scanning Microscopy studies proved that all investigated compounds were delivered to acidic organelles, the pH of which promoted an increased release of C-2028 from its nanoconjugates. Since the pH in normal cells is higher than in cancer cells, the release of C-2028 from its nanoconjugates is decreased in these cells. Additionally, we obtained the concentration profiles of C-2028 in the selected cells treated with unbound C-2028 or nanoconjugate by the HPLC analysis.
    View publication